# Edesa Biotech, Inc.: Form 8-K, filed Aug 8, 2025

- Company: [Edesa Biotech, Inc.](/companies/edsa.md) (CIK 1540159)
- Form: 8-K
- Filed: 2025-08-08
- Accepted by EDGAR: Aug 8, 2025, 16:40 ET
- Period: 2025-08-08
- Accession: 0001171843-25-005235
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1540159/000117184325005235/f8k_080825.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1540159/000117184325005235/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1540159/000117184325005235/f8k_080825.htm

Filed Aug 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-005235. Last ingested by Listed: Nov 5, 2026, 19:56 ET. No prices; not investment advice.